Cyber Monday 2024! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions

NABP Exam NAPLEX Topic 7 Question 15 Discussion

Actual exam question for NABP's NAPLEX exam
Question #: 15
Topic #: 7
[All NAPLEX Questions]

In a study where Rivaroxaban was compared to Enoxaparin to find total VTE following HIP replacement surgery, there were 17 total VTE out of 1513 patients in the Rivaraoaban group and 57 total VTE out of 1473 patient in the enoxaparin group.

What is the absolute risk reduction of using Rivaroxaban over Enoxaparin?

Show Suggested Answer Hide Answer
Suggested Answer: D

Absolute risk reduction: 0.027 = 2.7% (Event rate in enoxaparin group) -- (Event rate in rivaroxaban group) = (57/1473) -- (17/1513) = 0.02746


Contribute your Thoughts:

Currently there are no comments in this discussion, be the first to comment!


Save Cancel
az-700  pass4success  az-104  200-301  200-201  cissp  350-401  350-201  350-501  350-601  350-801  350-901  az-720  az-305  pl-300  

Warning: Cannot modify header information - headers already sent by (output started at /pass.php:70) in /pass.php on line 77